Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VXM01 |
Trade Name | |
Synonyms | |
Drug Descriptions |
VXM01 is a cancer vaccine consisted of attenuated bacteria carrying VEGFR2 expression vector, which may induce anti-angiogenic immune response (PMID: 26137397). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C99378 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + VXM01 | Avelumab VXM01 | 0 | 1 |
VXM01 | VXM01 | 0 | 0 |